Insiders Are Buying LXRX

JC Parets
August 2, 2022

The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.

Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.

There was also another Form 4 in Lexicon Pharmaceuticals filed by Director Raymond Debbane, who disclosed a purchase of roughly $2,456,500.

Reginald J. Brown, independent director at Blackstone $BX, disclosed a purchase of 3,100 shares, equivalent to $307,985 in his company’s stock in a Form 4.

Here’s The Hot List, with data through August 1, 2022:

The only 13D on our list was filed by Impactive Capital LP, which revealed an ownership stake of 9% in SLM Corporation $SLM.

Robert Stallings, an Independent director of Texas Capital Bancshares $TCBI, revealed an additional purchase of 4,000 shares of stock, as he continues to build a position.

In the options market, there was bullish flow in the social media app Pinterest $PINS and the small-cap biotech company Altimmune $ALT.

Stay tuned. We'll be back Wednesday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under